SEC Filing Details

Document Details

Form
Filing Date
Feb 24, 2015
Document Date
Dec 31, 2014
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
Celldex Therapeutics
Issuer
CELLDEX THERAPEUTICS, INC.

About us

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.

 

Our Pipeline